Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation.

R Singh, N Alavi, AK Singh, DJ Leehey - Diabetes, 1999 - Am Diabetes Assoc
Accumulation of mesangial matrix in diabetic nephropathy is caused by increased synthesis
and decreased degradation. We have previously demonstrated that incubation in high …

[HTML][HTML] Role of angiotensin II in diabetic nephropathy

DJ Leehey, AK Singh, N Alavi, R Singh - Kidney International, 2000 - Elsevier
Role of angiotensin II in diabetic nephropathy. Considerable evidence suggests that the
intrarenal renin-angiotensin system plays an important role in diabetic nephropathy …

[引用][C] Alavi N, Singh AK, and Leehey DJ

R Singh - Role of angiotensin II in glucose-induced inhibition of …, 1999

Angiotensin II and its receptors in the pathogenesis of diabetic nephropathy

DJ Leehey, AK Singh, R Singh - The Diabetic Kidney, 2006 - Springer
Diabetic nephropathy (DN) is characterized by accumulation of extracellular matrix (ECM) in
the kidney. Glomerular mesangial expansion and tubulo-interstitial fibrosis eventually leads …

Inhibition of intracellular angiotensin II formation blocks high glucose effect on mesangial matrix

R Singh, D Choubey, J Chen, DJ Leehey - Regulatory Peptides, 2009 - Elsevier
High glucose causes increased matrix synthesis by glomerular mesangial cells and
angiotensin II (Ang II) has been shown to mediate this effect of glucose. These studies …

[PDF][PDF] Angiotensin blockade and matrix synthesis by glomerular epithelial cells in high glucose: a further experimental insight into the pathophysiology of diabetic …

S Morano, R Cipriani, C Santangelo… - Clinica …, 2008 - clinicaterapeutica.it
Aims. Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor-1 (AT-1)
antagonists are used in the treatment of proteinuria of diabetic nephropathy. One of the …

Angiotensin II and its receptors in the diabetic kidney

KD Burns - American Journal of Kidney Diseases, 2000 - Elsevier
Studies using either angiotensin-converting enzyme inhibitors or type 1 (AT 1) angiotensin II
(ANG II)-receptor blockers indicate that ANG II is a mediator of progressive injury in diabetic …

Diabetic nephropathy. Mechanisms of mesangial matrix expansion.

CK Abrass - Western journal of medicine, 1995 - ncbi.nlm.nih.gov
Diabetic nephropathy, a major cause of morbidity and mortality in patients with diabetes
mellitus, is characterized by the progressive expansion of mesangial matrix that ultimately …

Diabetic vascular hypertrophy and albuminuria: Effect of angiotensin converting enzyme inhibition

TJ Allen, UL Hulthen, JR Rumble, M Jasik… - Journal of Diabetes and …, 1995 - Elsevier
The role of angiotensin-converting enzyme (ACE) inhibition with ramipril on mesenteric
vascular hypertrophy and urinary albumin excretion was explored in a normotensive model …

Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose

R Singh, AK Singh, N Alavi… - Journal of the American …, 2003 - journals.lww.com
Previous studies have shown that glucose increases angiotensin II (AngII) levels in rat
glomerular mesangial cells and that AngII mediates the inhibitory effects of high glucose on …